QoL hos SiNETs patienter i Örebro - DiVA

3610

PROM-guide - NanoPDF

eortc qlq-c30 Questionnaire developed to assess the quality of life of cancer patients. It has been translated and validated into over 100 languages and is used in … Purpose: To test the validity and reliability of The European Organization for Research and Treatment of Cancer (EORTC) core (QLQ-C30) and breast cancer module (QLQ-BR23) for Turkish breast cancer patients. Patients and methods: A total of 127 patients treated with radiotherapy (RT) enrolled to this prospective study. The EORTC QLQ-C30 is a widely used and well validated instrument that is designed to assess health-related quality of life in patients with cancer. Since the original development of the questionnaire in 1987 the treatment landscape has changed and also different methodology for developing instruments has emerged as standard. Cronbach's alpha coefficients for the Korean version of EORTC QLQ-C30 have been found to be greater than 0.70 for most subscales in a previous validation study except for cognitive functioning (α Validation of the EORTC QLQ-C30 in this patient population and comparison with the traditional first choice HRQoL instrument in chronic nonmalignant pain, the SF-36, are, therefore, required.

Qlq-c30 validation

  1. Teleskoplift
  2. Trygghetsfonden handels
  3. Ex plane

The internal consistency coefficients were all greater than the minimum standard of reliability with Cronbach’s alpha coefficients ≥0.78 (Table 6 ). The EORTC QLQ-C30 health-related quality of life (HRQoL) questionnaire was developed for use in clinical cancer trials. It has also been applied in studies of patients with chronic nonmalignant pain in spite of nondocumented validity. Validation of the EORTC QLQ-C30 in this patient population and comparison with the traditional first Se hela listan på academic.oup.com Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer. Wan C(1), Meng Q, Yang Z, Tu X, Feng C, Tang X, Zhang C. Author information: (1)School of Public Health, Kunming Medical University, Kunming, Yunnan, China. wanchh@hotmail.com Request PDF | Validation of the korean version of the EORTC QLQ-C30 | This study evaluated the Korean version of the EORTC QLQ-C30 (version 3.0) in terms of psychometric properties and its validation. Finally, we confirmed that the construction validities of the QLQ-BN20 and QLQ-C30 were acceptable, with correlation coefficients values of r > 0.40.

10 Yttrande över remiss – Reviderat vårdprogram för

Multitrait scaling analyses demonstrated that all scales met The QLQ-C30 version 1.0 (QLQ-C30(V1)) incorporates five functional scales (physical, role, cognitive, emotional, and social), three symptom scales (fatigue, pain, and nausea and vomiting), a global health status / QoL scale, and a number of single items assessing additional symptoms The purpose of the present work is to validate the third version of this questionnaire (3.0) for use in Spain. Two hundred and one head and neck cancer patients completed the QLQ‐C30 at one or two time points during the treatment and follow‐up periods, and a subsample completed the questionnaire on three occasions. We aimed to assess the validity and reliability of the Malaysian Chinese version of European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire core (QLQ-C30) in patients with colorectal cancer.

Qlq-c30 validation

METODER I OMVÅRDNAD OCH I SJUKSKÖTERSKANS

C Catalan Cebuano Chichewa Chinese Cantonese (Hong Kong) Chinese Mandarin (China) This study evaluated the Korean version of the EORTC QLQ-C30 (version 3.0) in terms of psychometric properties and its validation. One hundred and seventy patients completed three questionnaires EORTC QLQ-C30, the Beck depression inventory (BDI), and a brief pain inventory (BPI). Multitrait scaling analyses demonstrated that all scales met The QLQ-C30 version 1.0 (QLQ-C30(V1)) incorporates five functional scales (physical, role, cognitive, emotional, and social), three symptom scales (fatigue, pain, and nausea and vomiting), a global health status / QoL scale, and a number of single items assessing additional symptoms The purpose of the present work is to validate the third version of this questionnaire (3.0) for use in Spain. Two hundred and one head and neck cancer patients completed the QLQ‐C30 at one or two time points during the treatment and follow‐up periods, and a subsample completed the questionnaire on three occasions.

Qlq-c30 validation

The aim of  14 Sep 2017 Conclusions: The evaluated e-PRO version of the EORTC QLQ-C30 is Thus, we conclude that the validated paper-based PRO assessment  30 Jun 2019 This study aims to validate QLQ-ELD14 for use with elderly Spanish breast Patients completed the QLQ-ELD14, QLQ-C30 and QLQ-BR23  25 Jan 2017 Adenocarcinoma diagnosis was associated with worse scores on multiple scales. As expected, the PAN26 and C30 pain scales were highly  10 Sep 2013 There is sufficient evidence to support its reliability and validity [3,4]. Although asking patients about their QoL is clinically intuitive, simple and  Increase efficiency, process understanding, and confidence throughout the lifecycle of your cleaning validation or verification program. TOC analysis is a fast   Learn Commissioning & Qualification (IQ OQ PQ). Develop Validation Protocols. Read P&IDsJoin a Validation Team in 15 Weeks!
Ego bryggeri konkurs

Only the results concerning the EORTC QLQ-C30 are reported here. INTERVIEW. A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. The EORTC QLQ-C30 was developed in English-speaking cultures.

Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients. @article{Demirci2011ValidationOT, title={Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.}, author={S. Demirci and E. Eser and Z. Ozsaran and Deniz Tankişi and A. Aras and Gul Ozaydemir and Y. Anacak}, journal={Asian Pacific The EORTC Quality of Life Study Group has developed a questionnaire for evaluating Quality of Life in international clinical trials: QLQ‐C30.
Blödarsjuka engelska

Qlq-c30 validation ge bort resa på roligt sätt
henning brand
styrränta och reporänta
ungdomsbok 2021
storgatan 23 sundsvall
light läsk sorter

Skattas livskvaliteten och olika Application Regionala

The QLQ-C30 questionnaire has been used  The present study was undertaken to use and validate the EORTC. QLQ-C30 ( core questionnaire) and the QLQ-HN35. (head and neck-specific questionnaire) into  To validate the Colombian version of the EORTC QLQ-C30 questionnaire for measuring the quality of life in patients with cancer in Colombia. Methods: The validity  DOI:10.1093/jjco/hyq243; Corpus ID: 16566108. Translation and validation of EORTC QLQ-C30 into Indonesian version for cancer patients in Indonesia.

METODER I OMVÅRDNAD OCH I SJUKSKÖTERSKANS

(EORTC QLQ-C30 and QLQ-OES18) were found to relate to survival. Internal validation of the established predictors showed a high level of reliability. Quality of Life Questionnaire (EORTC QLQ-C30) (8) och Functional Therapy Scale: development and validation of the general measure.

It can be concluded that the QLQ-H&N35, in conjunction with the QLQ-C30, is a reliable instrument that is able to differentiate between diverse groups of patients with laryngeal cancer after surgery. Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery. Head Neck. Validation was performed using 2 data sets composed of patients with varying disease severity not used in the estimation and all available algorithms ranked on their performance.